SCHEMBL7322255

SCHEMBL7322255

O=c1[nH]c2ccccc2c(=O)n1CCN1CCC(c2noc3cc(F)ccc23)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.64
▸ HTR2A P28223 3/20 0.62
▸ HTR2C P28335 2/20 0.62
▸ DRD2 P14416 3/20 0.60
▸ SLC6A4 P31645 2/20 0.60
▸ HTR1A P08908 2/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ ADRA2B P18089 1/20 0.58
▸ ADRA2C P18825 1/20 0.58
▸ DRD1 P21728 1/20 0.58
▸ DRD4 P21917 1/20 0.58
▸ HTR1D P28221 1/20 0.58
▸ HTR1B P28222 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7285993 0.91 ACHE (0.62) ACHEHTR2AHTR2CDRD2SLC6A4
SCHEMBL10896910 0.85 DRD2 (0.61) ACHEHTR2ADRD2SLC6A4
SCHEMBL1545611 0.82 ACHE (0.93) ACHEHTR2AHTR2CDRD2SLC6A4
SCHEMBL9423869 0.82 SLC18A2 (0.58) HTR2AHTR2CDRD2SLC6A4HTR1A
SCHEMBL1545272 0.81 ACHE (0.63) ACHEHTR2AHTR2CDRD2SLC6A4
SCHEMBL11244560 0.80 HTR1A (0.55) HTR2ADRD2HTR1A
SCHEMBL10896514 0.79 DRD2 (0.62) ACHEDRD2SLC6A4
SCHEMBL17474575 0.79 SLC18A2 (0.72) HTR2AHTR2CDRD2SLC6A4HTR1A
SCHEMBL1544931 0.79 ACHE (0.71) ACHEHTR2AHTR2CDRD2SLC6A4
Bromide SCHEMBL10894851 0.79 HTR1A (0.54) HTR2ADRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4804663-A PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1989-02-14 — — US disclosed
EP-0196132-A2 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-01 — — EP disclosed
Send feedback